cyc 202 has been researched along with head activator peptide in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (head activator peptide) | Trials (head activator peptide) | Recent Studies (post-2010) (head activator peptide) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 68 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boels, K; Glassmeier, G; Hampe, W; Herrmann, D; Kojima, I; Riedel, IB; Schaller, HC; Schwarz, JR | 1 |
1 other study(ies) available for cyc 202 and head activator peptide
| Article | Year |
|---|---|
The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC.
Topics: Androstadienes; Animals; Benzylamines; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Membrane; CHO Cells; COS Cells; Cricetinae; Enzyme Inhibitors; Humans; Imidazoles; Microscopy, Fluorescence; Models, Biological; Neurons; Neuropeptides; Patch-Clamp Techniques; Pertussis Toxin; Protein Transport; Purines; Pyrrolidonecarboxylic Acid; Recombinant Fusion Proteins; Roscovitine; Signal Transduction; Sulfonamides; TRPV Cation Channels; Virulence Factors, Bordetella; Wortmannin | 2001 |